Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
¸¿Å×¶óÁÖ500mg/50ml - »õâ
|
F.Hoffmann-La Roche |
E01840692 | Rituximab | Àü¹®ÀǾàǰ | ±Þ¿© |
|
¸¿Å×¶óÁÖ - »õâ
|
Çѱ¹·Î½´ |
E01840492 | Rituximab | Àü¹®ÀǾàǰ | »èÁ¦ |
|
¸¿Å×¶óÁÖ - »õâ
|
Çѱ¹·Î½´ |
E01840691 | Rituximab | Àü¹®ÀǾàǰ | ±Þ¿© |
|
¸¿Å×¶óÁÖ - »õâ
|
Çѱ¹·Î½´ |
E01840491 | Rituximab | Àü¹®ÀǾàǰ | ±Þ¿© |
| rituximab |
A type of monoclonal antibody used in cancer detection or therapy. Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells.
Ãâó: www.stjude.org/glossary
|
|---|---|
| rituximab |
(or Rituxan) is a commercial humanized antibody used for treating lymphomas.
Ãâó: www.ariusresearch.com/glos.html
|
| rituximab |
an immunotherapy drug used to treat a variety of non-Hodgkin's lymphomas. Clinical studies are underway to determine the efficacy of Rituxan in treating chronic lymphomcytic leukemia (CLL), Waldenstrom's macroglobulinemia, and other cancers of the blood.
Ãâó: www.leukemialymphomafyi.com/cancer_glossary.html
|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|